Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Cancer
|
April 22, 2011
Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study
Jelena Klawitter, Jost Klawitter, Jennifer Gurshtein, et al.
Current Opinion in Pharmacology
|
October 19, 2010
Regulation of specific target genes and biological responses by estrogen receptor subtype agonists
Dale C Leitman, Sreenivasan Paruthiyil, Omar I Vivar, et al.
International Journal of Cancer
|
December 23, 2009
Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid
Ruth Chu, Xiaoyue Zhao, Chandi Griffin, et al.
Menopause (New York, N.Y.)
|
February 3, 2009
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial
Deborah Grady, George F Sawaya, Karen C Johnson, et al.
The Journal of Biological Chemistry
|
April 21, 2010
Estrogen receptor beta binds to and regulates three distinct classes of target genes
Omar I Vivar, Xiaoyue Zhao, Elise F Saunier, et al.
International Journal of Molecular Sciences
|
August 7, 2021
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
Raquel Centeio, Jiraporn Ousingsawat, Inês Cabrita, et al.
Molecular and Cellular Endocrinology
|
September 12, 2009
Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen
Nitzan Levy, Sreenivasan Paruthiyil, Xiaoyue Zhao, et al.
Molecular and Cellular Endocrinology
|
December 9, 2008
Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements
Lonnele J Ball, Nitzan Levy, Xiaoyue Zhao, et al.
Breast Cancer Research and Treatment
|
November 18, 2006
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
Hope Rugo, Emma Shtivelman, Alejandra Perez, et al.
Molecular and Cellular Endocrinology
|
January 8, 2008
Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist
Jennifer E Mersereau, Nitzan Levy, Richard E Staub, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Cancer
|
April 22, 2011
Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study
Jelena Klawitter, Jost Klawitter, Jennifer Gurshtein, et al.
Current Opinion in Pharmacology
|
October 19, 2010
Regulation of specific target genes and biological responses by estrogen receptor subtype agonists
Dale C Leitman, Sreenivasan Paruthiyil, Omar I Vivar, et al.
International Journal of Cancer
|
December 23, 2009
Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid
Ruth Chu, Xiaoyue Zhao, Chandi Griffin, et al.
Menopause (New York, N.Y.)
|
February 3, 2009
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial
Deborah Grady, George F Sawaya, Karen C Johnson, et al.
The Journal of Biological Chemistry
|
April 21, 2010
Estrogen receptor beta binds to and regulates three distinct classes of target genes
Omar I Vivar, Xiaoyue Zhao, Elise F Saunier, et al.
International Journal of Molecular Sciences
|
August 7, 2021
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
Raquel Centeio, Jiraporn Ousingsawat, Inês Cabrita, et al.
Molecular and Cellular Endocrinology
|
September 12, 2009
Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen
Nitzan Levy, Sreenivasan Paruthiyil, Xiaoyue Zhao, et al.
Molecular and Cellular Endocrinology
|
December 9, 2008
Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements
Lonnele J Ball, Nitzan Levy, Xiaoyue Zhao, et al.
Breast Cancer Research and Treatment
|
November 18, 2006
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
Hope Rugo, Emma Shtivelman, Alejandra Perez, et al.
Molecular and Cellular Endocrinology
|
January 8, 2008
Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist
Jennifer E Mersereau, Nitzan Levy, Richard E Staub, et al.
Page
of 7